1. Home
  2. CLGN vs ECOR Comparison

CLGN vs ECOR Comparison

Compare CLGN & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLGN
  • ECOR
  • Stock Information
  • Founded
  • CLGN 2004
  • ECOR 2005
  • Country
  • CLGN Israel
  • ECOR United States
  • Employees
  • CLGN N/A
  • ECOR N/A
  • Industry
  • CLGN Industrial Specialties
  • ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • CLGN Health Care
  • ECOR Health Care
  • Exchange
  • CLGN Nasdaq
  • ECOR Nasdaq
  • Market Cap
  • CLGN 33.8M
  • ECOR 40.0M
  • IPO Year
  • CLGN N/A
  • ECOR 2018
  • Fundamental
  • Price
  • CLGN N/A
  • ECOR $5.14
  • Analyst Decision
  • CLGN Strong Buy
  • ECOR Strong Buy
  • Analyst Count
  • CLGN 2
  • ECOR 2
  • Target Price
  • CLGN $11.50
  • ECOR $25.50
  • AVG Volume (30 Days)
  • CLGN 257.5K
  • ECOR 46.6K
  • Earning Date
  • CLGN 11-26-2025
  • ECOR 11-12-2025
  • Dividend Yield
  • CLGN N/A
  • ECOR N/A
  • EPS Growth
  • CLGN N/A
  • ECOR N/A
  • EPS
  • CLGN N/A
  • ECOR N/A
  • Revenue
  • CLGN $2,402,000.00
  • ECOR $27,700,000.00
  • Revenue This Year
  • CLGN $1,617.28
  • ECOR $24.48
  • Revenue Next Year
  • CLGN $83.54
  • ECOR $44.35
  • P/E Ratio
  • CLGN N/A
  • ECOR N/A
  • Revenue Growth
  • CLGN 248.62
  • ECOR 30.16
  • 52 Week Low
  • CLGN $1.31
  • ECOR $4.16
  • 52 Week High
  • CLGN $4.99
  • ECOR $19.49
  • Technical
  • Relative Strength Index (RSI)
  • CLGN 45.87
  • ECOR 49.61
  • Support Level
  • CLGN $2.11
  • ECOR $4.80
  • Resistance Level
  • CLGN $2.44
  • ECOR $5.34
  • Average True Range (ATR)
  • CLGN 0.22
  • ECOR 0.26
  • MACD
  • CLGN -0.03
  • ECOR 0.03
  • Stochastic Oscillator
  • CLGN 23.36
  • ECOR 58.62

About CLGN CollPlant Biotechnologies Ltd

CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.

About ECOR electroCore Inc.

electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.

Share on Social Networks: